AWM — Airway Medix SA Cashflow Statement
0.000.00%
- PLN39.42m
- PLN51.93m
- PLN0.01m
Annual cashflow statement for Airway Medix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
| 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Net Income/Starting Line | -1.99 | -9.37 | -37.4 | -3.28 | -11.7 | 
| Depreciation | |||||
| Non-Cash Items | -0.116 | -12.7 | 34.6 | 7.95 | 5.43 | 
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.146 | 16.3 | 2.34 | -8.87 | -1.36 | 
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.25 | -5.85 | -0.442 | -4.2 | -7.59 | 
| Capital Expenditures | -5.02 | 0 | -0.13 | 0 | -0.019 | 
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -0.053 | 
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.02 | 0 | -0.13 | 0 | -0.072 | 
| Financing Cash Flow Items | — | — | — | 0.548 | 0 | 
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.73 | 3.71 | 0.55 | 4.85 | 9.13 | 
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.51 | -2.19 | -0.022 | 0.653 | 1.46 |